This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Physiologic Insulin Replacement: Practical Strategies for Insulin Initiation and Titration of Long-acting Insulins

Physiologic Insulin Replacement: Practical Strategies for Insulin Initiation and Titration of Long-acting Insulins

Format

Patient Case Study

Time to Complete

1 hour

Released

April 30, 2018

Expires

April 30, 2019
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour

Accredited Provider



Provided by Physicians' Education Resource®, LLC (PER®)

Commercial Supporter

This activity is supported by an educational grant from Sanofi US.

Program Description

This activity is designed to update clinicians on the appropriate use of insulin to optimize therapy in patients with diabetes. The efficacy and safety of newer therapies will be discussed as well as the proper timing of insulin therapy initiation. As part of the activity, the faculty will review treatment guidelines and make practical suggestions on how to overcome barriers to insulin therapy.

Intended Audience

This CME/CE activity is intended for endocrinologists, primary care physicians, internal medicine professionals, clinical diabetes educators (CDEs), nurses, physician assistants (PAs), and nurse practitioners (NPs).

Educational Objectives

After completing this activity, clinicians should be better able to:
  • Articulate clinical strategies for the timely initiation and modification, and intensification of insulin therapy to achieve glycemic control
  • Compare clinical data on new insulin formulations and combination insulin/incretin therapies, including pharmacological profiles surrounding efficacy and safety, such as effects on hypoglycemia and nocturnal hypoglycemia and weight gain
  • Explain novel strategies to optimize insulin therapy in clinical practice to improve glucose control, reduce risk of weight gain and hypoglycemia, and increase patient acceptance and adherence
  • Utilize a collaborative team-based approach to patient care that safely appropriately and effectively transition patients to concentrated insulin and insulin combinations

Conflict Of Interest Disclosure Policy

As a sponsor accredited by the ACCME, it is the policy of PER to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER is required by ACCME to resolve all COI. PER has identified and resolved all COI prior to the start of this activity by using a multistep process.

Faculty

Kenneth Cusi, MD, FACE, FACP
Professor and Chief
Department of Medicine
Division of Endocrinology, Diabetes and Metabolism
University of Florida
Gainesville, FL

Dr. Cusi discloses the following:
Consultant: Bristol-Myers Squibb, Gilead Sciences, Lilly, and Janssen
Grant/Research Support: Janssen Pharmaceuticals, Novartis, Cirius Therapeutics, Novo Nordisk, and Zydus Pharmceuticals

Accredited Provider Disclosure

The staff of Physicians' Education Resource®, LLC, has no relevant financial relationships with commercial interests to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians, and is a provider approved by the California Board of Registered Nursing (CBRN).

Designation Statement

Physicians' Education Resource®, LLC designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians, and is a provider approved by the California Board of Registered Nursing (CBRN).

Designation Statement

Physicians' Education Resource®, LLC designates this enduring material for a maximum for 1.00 Contact Hour.

Disclosure of Unlabeled Use

This activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to the diagnostic, treatment, and management options for a specific patient’s medical condition.

Disclaimer

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.

Instructions

In order to receive credit, participants must complete the pre-assessment questions, view the activity in its entirety, and complete the post-test and program evaluation. Participants must also score at least 70% on the post-test. You will receive a digital copy of your credit certificates at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact ceinfo@permedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue